Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
24.86
+1.20 (5.07%)
At close: Jun 23, 2026, 4:00 PM EDT
24.78
-0.08 (-0.32%)
After-hours: Jun 23, 2026, 4:04 PM EDT
Surrozen Revenue
Surrozen had revenue of $5.00M in the quarter ending March 31, 2026, with 408.65% growth. This brings the company's revenue in the last twelve months to $7.49M, down -35.61% year-over-year. In the year 2025, Surrozen had annual revenue of $3.48M, down -67.37%.
Revenue (ttm)
$7.49M
Revenue Growth
-35.61%
P/S Ratio
38.52
Revenue / Employee
$170,318
Employees
44
Market Cap
288.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.48M | -7.18M | -67.37% |
| Dec 31, 2024 | 10.66M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 12.50M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MacroGenics | 157.08M |
| Niagen Bioscience | 130.42M |
| Bicycle Therapeutics | 63.50M |
| Invivyd | 55.87M |
| Zentalis Pharmaceuticals | 26.87M |
| Cartesian Therapeutics | 1.78M |
| InflaRx | 33.82K |
| Lyell Immunopharma | 31.00K |
SRZN News
- 5 weeks ago - Surrozen Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 5 weeks ago - Surrozen Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Surrozen to Present at Upcoming Healthcare Investor Conference - GlobeNewsWire
- 6 weeks ago - Surrozen price target raised to $44 from $36 at H.C. Wainwright - TheFly
- 6 weeks ago - Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year - TheFly
- 6 weeks ago - Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Surrozen Earnings release: Q1 2026 - Filings
- 6 weeks ago - Surrozen Quarterly report: Q1 2026 - Filings